3558 results for «384»

Filter By

3558 results

TAVI complex cases: intravascular hemolysis, Heyde syndrome & more

08 Feb 2025 – From PCR Tokyo Valves 2025

This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.

TAVI complex cases: intravascular hemolysis, Heyde syndrome & more

High-risk TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...

High-risk TAVI

The value of WATCHMAN therapy - Who should we treat?

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...

The value of WATCHMAN therapy - Who should we treat?

Post-procedure complications: leaflet thrombus, hemolytic anemia & more

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to discover a range of post-procedure complications that can arise after TAVI, including subacute leaflet thrombus, hemolytic anemia after surgical aortic valve replacement, late migration of papillary fibroelastoma, sinus sequestration, delayed left main occlusion, and high-grade atrioventricular block. Additionally, learn about techniques to...

Post-procedure complications: leaflet thrombus, hemolytic anemia & more

Future devices for structural heart interventions

08 Feb 2025 – From PCR Tokyo Valves 2025

Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.

Future devices for structural heart interventions

Mitral valve-in-valve and valve-in-ring electrosurgery

08 Feb 2025 – From PCR Tokyo Valves 2025

Mitral valve-in-valve and valve-in-ring electrosurgery

M-TEER for primary mitral regurgitation

08 Feb 2025 – From PCR Tokyo Valves 2025

In this PCR Tokyo Valves 2025 session on M-TEER for primary mitral regurgitation, gain valuable insights starting with an overview of current TEER devices. Benefit from four case studies that highlight the features of these devices, explore strategies to prevent mitral regurgitation recurrence post-TEER, and delve...

M-TEER for primary mitral regurgitation

TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke

08 Feb 2025 – From PCR Tokyo Valves 2025

Gain valuable insights into the management of complications associated with Transcatheter Aortic Valve Implantation (TAVI). Discover the latest evidence on hemolytic anemia, the predictive value of the hemoglobin to creatinine ratio, outcomes of transcarotid TAVI, a case study on prosthetic valve endocarditis, the role of diastolic...

TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke

Late-Breaking Trial session

08 Feb 2025 – From PCR Tokyo Valves 2025

Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...

Late-Breaking Trial session

Lifetime management - First valve choice matters

08 Feb 2025 – From PCR Tokyo Valves 2025

In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.

Lifetime management - First valve choice matters

Mitral challenging anatomy

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to discover various challenging mitral valve anatomies and interventions. From unavoidable iatrogenic mitral stenosis following transcatheter edge-to-edge repair to successful procedures with the PASCAL device for severe mitral regurgitation, this session provides valuable insights into complex mitral valve cases.

Mitral challenging anatomy

Lifetime management

08 Feb 2025 – From PCR Tokyo Valves 2025

This PCR Tokyo Valves 2025 session explores the latest insights into TAVR explantation. It begins with the management of patients with longer life expectancy, then delves into surgical aortic valve replacement, aortic root enlargement, and commissural alignment—key techniques that may improve reintervention outcomes. The session also...

Lifetime management

TAVI and coronary artery disease

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the complex interplay between TAVI and coronary artery disease in this comprehensive session. Explore the decision-making process for optimal sequencing of PCI and TAVI, and examine cases of acute myocardial infarction due to coronary embolism and delayed coronary obstruction following TAVI. Gain insights into...

TAVI and coronary artery disease

TAV-in-TAV

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this PCR Tokyo Valves 2025 session on TAV-in-TAV to discover essential insights on optimizing the procedure. Learn how CT analysis and precise measurements are critical for success, and why coronary protection, chimney stenting, and leaflet modification must be considered in high-risk cases. Experts discuss key...

TAV-in-TAV

Nightmare in TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this session replay featuring two challenging cases: valve embolisation with a balloon-expandable valve and coronary obstruction with a self-expandable valve. Learn key lessons from the first case, including the importance of secure pacing, avoiding damage to the descending aorta while retrieving the embolised valve, and...

Nightmare in TAVI

My patient with complex angiogram

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to learn how to efficiently perform intracoronary imaging and physiological assessment in your cath lab, to learn how to interpret IVUS and OCT images and to implement intracoronary physiology and imaging tools into the decision making in a MVD patient.

My patient with complex angiogram

My patient with STEMI

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to understand the challenges of primary PCI, to discuss contemporary approaches to multivessel PCI in STEMI and to learn how to prevent and manage complications during primary PCI.

My patient with STEMI

Our patient with a highly calcified vessel

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to define a step-by-step strategy to deal with calcified lesions, discover how OCT can support your decision making and to learn how to learn how to use ROTABLATOR for an effective and safe plaque debulking.

Our patient with a highly calcified vessel

Bifurcation PCI with provisional technique

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to learn how to assess bifurcation lesions, to get familiar with the steps of provisional approach and to understand causes and solutions for the most common pitfalls.

Bifurcation pci with provisional 

The catheter-based treatment revolution is just getting started

19 Nov 2023 – From PCR London Valves 2023

Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.

The catheter-based treatment revolution is just getting started
Didn’t find what you were looking for?